The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.
SPOT-Met (Weill Cornell Medicine): SPOT-Met (Spatial Predictors Of Tropism and Metastasis), a 1,000-tumor colorectal cancer program described as the world's largest colorectal cancer multimodal ...
Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, ...
We combine advanced technologies such as spatial transcriptomics, multiplexed imaging, and in situ sequencing to map cellular components in their native tissue context. Obtain high-resolution data ...
Takara Bio USA collaborates with Illumina on a single-cell-resolution spatial mapping workflow, presented at AGBT 2026.
A new spatial transcriptomic technology captures RNA patterns without requiring expensive imaging ...
IRB Barcelona has launched Spain’s first fully integrated spatial omics platform, allowing researchers to capture cells' spatial context.
Hosted on MSN
What Is Spatial Transcriptomics?
Spatial transcriptomics is a technique that provides information about gene expression patterns within intact tissues. This technology employs various methodologies, including in situ sequencing (ISS) ...
Left: Imaging of lamin A/C structures in a physically expanded nucleus from an individual with progeria. Right: Same, but with 3D genomic reads overlaid in their original spatial locations, colored by ...
Takara Bio USA, Inc. ("Takara Bio USA"), a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced a series of updates to its spatial biology product portfolio, extending its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results